Developing long-acting growth hormone formulations

被引：27
|
作者：
Cawley, Pippa [1 ]
Wilkinson, Ian [1 ]
Ross, Richard J. [1 ]
机构：
[1] Univ Sheffield, Acad Unit Diabet Endocrinol & Reprod, Sheffield S10 2RX, S Yorkshire, England
来源：
CLINICAL ENDOCRINOLOGY | 2013年 / 79卷 / 03期
关键词：
PREPARATION NUTROPIN DEPOT; GH PREPARATION; PHARMACODYNAMIC CHARACTERISTICS; FACTOR-I; PHARMACOKINETICS; CHILDREN; EFFICACY; LB03002; FUSION; SAFETY;
D O I：
10.1111/cen.12240
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Daily recombinant growth hormone (GH) restores normal growth and body composition in GH-deficient children and adults; however, daily injections are inconvenient and can be distressing for some children. On top of this compliance is a problem in up to 75% of children. Developing long-acting GH formulations has proved challenging, and questions remain regarding safety and efficacy. In this review, we focus on the rationale for generating long-acting GH agonists and the technologies being developed to deliver prolonged exposure to GH.
引用
收藏
页码：305 / 309
页数：5
相关论文
共 50 条
  • [31] Novel long-acting crystal formulation of human growth hormone
    Govardhan, C
    Khalaf, N
    Jung, CW
    Simeone, B
    Higbie, A
    Qu, S
    Chemmalil, L
    Pechenov, S
    Basu, SK
    Margolin, AL
    PHARMACEUTICAL RESEARCH, 2005, 22 (09) : 1461 - 1470
  • [32] A Survey on Clinician Perceptions of Long-Acting Growth Hormone Analogs
    Howard-James, Naomi
    Padidela, Raja
    Raimann, Adalbert
    Gevers, Evelien
    Semler, Oliver
    McDonnell, Ciara
    HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 1): : 308 - 309
  • [33] Novel Long-Acting Crystal Formulation of Human Growth Hormone
    Chandrika Govardhan
    Nazer Khalaf
    Chu W. Jung
    Ben Simeone
    Amy Higbie
    Susan Qu
    Letha Chemmalil
    Sergey Pechenov
    Sujit K. Basu
    Alexey L. Margolin
    Pharmaceutical Research, 2005, 22 : 1461 - 1470
  • [34] Rationale for Long-acting Growth Hormone Therapy and Future Aspects
    Cetinkaya, Semra
    Eren, Erdal
    Erdogan, Furkan
    Darendeliler, Feyza
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2025, 17 (01) : 1 - 8
  • [35] Bioavailability of two long-acting formulations of methylphenidate
    Markowitz, JS
    Straughn, A
    Patrick, KS
    DeVane, CL
    Pestreich, L
    Lee, J
    Wang, YF
    Muniz, R
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (04) : 417 - 418
  • [36] Guidance for the treatment of adult growth hormone deficiency with somapacitan, a long-acting growth hormone preparation
    Bidlingmaier, Martin
    Biller, Beverly M. K.
    Clemmons, David
    Jorgensen, Jens Otto L.
    Nishioka, Hiroshi
    Takahashi, Yutaka
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [37] Effects of different doses of long-acting growth hormone in treating children with growth hormone deficiency
    Xia, Wei
    Wang, Ting
    Pan, Jia-Yan
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (28) : 6715 - 6724
  • [38] Long-term effectiveness and safety of long-acting growth hormone preparation in children with growth hormone deficiency
    Kang, Eungu
    Chung, Lindsey Yoojin
    Rhie, Young-Jun
    Lee, Kee-Hyoung
    Nam, Hyo-Kyoung
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2024, 37 (12): : 1036 - 1046
  • [39] Long-Acting Human Growth Hormone Analogue by Noncovalent Albumin Binding
    Ramirez-Andersen, Henrik S.
    Behrens, Carsten
    Buchardt, Jens
    Fels, Johannes J.
    Folkesson, Charlotta G.
    Chen Jianhe
    Norskov-Lauritsen, Leif
    Nielsen, Per F.
    Reslow, Mats
    Rischel, Christian
    Su, Jing
    Thygesen, Peter
    Wiberg, Charlotte
    Zhao, Xin
    Wenjuan, Xia
    Johansen, Nils L.
    BIOCONJUGATE CHEMISTRY, 2018, 29 (09) : 3129 - 3143
  • [40] Metabolism of somapacitan, a long-acting growth hormone derivative, in human subjects
    Damholt, Birgitte B.
    Bjelke, Mads
    Helleberg, Hans
    Rasmussen, Michael H.
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 310 - 310
12345